These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 371293)

  • 1. [Reactogenicity and immunological effectiveness of an oral cholera chemical vaccine in a limited controlled experiment with human revaccination].
    Sumarokov AA; Ivanov NR; Lelikov VL; Dzhaparidze MN; Karaeva LT
    Zh Mikrobiol Epidemiol Immunobiol; 1978; (12):87-92. PubMed ID: 371293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study of immunological efficacy of the oral chemical cholera vaccine on experimental animals].
    Dzhaparidze MN; Egorova VD; Karaeva LT; Sumarokov AA; Gor'kova Av
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):115-9. PubMed ID: 1007720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The determination of the optimal inoculation dose of an oral cholera chemical bivalent vaccine in a controlled experiment].
    Sumarokov AA; Ivanov NR; Dzhaparidze MN; Reznikov IuB; Rystsova EA; Nikitina GP; Matusevich LIa; Popov AA; Plotnikova MN; Shustov VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):55-62. PubMed ID: 2099071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The determination of the optimal inoculation dose of an oral cholera bivalent chemical vaccine in a controlled trial of the vaccination of children and adolescents].
    Sumarokov AA; Dzhaparidze MN; Eliseev IuIu; Nikitina GP; Poliakov KA; Kazakova ES; Meleshchenko MV; Tsareva NM; Reznikov IuB; Adamova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):55-60. PubMed ID: 8067145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1994 Sep; 12(12):1078-82. PubMed ID: 7998416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the immunogenicity and immunological effectiveness of choleragen anatoxin (data from a controlled epidemiological experiment). II. The cahracterisitcs of choleragen anatoxin immunogenicity compared with corpuscular cholera vaccines administered by syringe and by using a jet injector].
    Sumarokov AA; Lelikov VL; Dzhaparidze MN; Karaeva LT; Derteva II
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):31-7. PubMed ID: 4615518
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reactogenicity and immunologic effectiveness of cholerogen-anatoxin. Feasibility of revaccination with cholerogen-anatoxin, determination of optimal doses and times for administration].
    Sumarokov AA; Ivanov NR; Lelikov VL; Dzhaparidze MN; Karaeva LT
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):85-91. PubMed ID: 1024451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The characteristics of the reactogenicity and immunological activity of a new cholera bivalent chemical vaccine based on the results of controlled trials].
    Sumarokov AA; Ivanov NR; Dzhaparidze MN; Rystsova EA; Reznikov IuB; Matusevich LIa; Nikitina GP; Eliseev IuIu; Adamova GV; Plotnikova MN
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):55-8. PubMed ID: 1719716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactogenicity and immunogenicity of oral cholera vaccine in Thai volunteers.
    Migasena S; Pitisuttitham P; Supanaranond W; Desakorn V; Prayurahong B; Suntharasamai P
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):423-8. PubMed ID: 3217824
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the immunogenicity and immunological effectiveness of choleragen anatoxin (data from a controlled epidemiological experiment). I. The characteristics of choleragen anatoxin compared wiht corpuscular cholera vaccines administered by syringe and by using a jet injector].
    Lelikov VL; Sumarokov AA; Ivanov NR; Fedenev VG; Poliakov KA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):25-30. PubMed ID: 4615517
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic immunity of experimental animals immunized with cholera vaccines].
    Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
    Wasserman SS; Losonsky GA; Noriega F; Tacket CO; Castañeda E; Levine MM
    Vaccine; 1994 Aug; 12(11):1000-3. PubMed ID: 7975839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.
    Chen WH; Garza J; Choquette M; Hawkins J; Hoeper A; Bernstein DI; Cohen MB
    Clin Vaccine Immunol; 2015 Jan; 22(1):129-35. PubMed ID: 25410205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
    Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh.
    Sack DA; Clemens JD; Huda S; Harris JR; Khan MR; Chakraborty J; Yunus M; Gomes J; Siddique O; Ahmed F
    J Infect Dis; 1991 Aug; 164(2):407-11. PubMed ID: 1856488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of revaccination in persons inoculated primarily with whole-cell and toxoid cholera vaccines].
    Kiseleva IE; Domaradskiĭ IV; Erokhin EP; Kirdeev VK; Kiseleva VI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):64-7. PubMed ID: 4409388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.